Herpes Simplex on the Abdomen: Presentation, Diagnosis, and Antiviral Management

Herpes Simplex Virus (HSV) on the Trunk

While HSV-1 typically affects the orolabial region and HSV-2 the anogenital region, both can infect any cutaneous site. Abdominal (truncal) herpes occurs via:

Autoinoculation from primary site
Direct contact with infected partner's lesion
Reactivation in thoracic/lumbar dermatomes (zosteriform HSV)
Wrestling/herpes gladiatorum (HSV-1, skin-to-skin)

Clinical Features

Prodrome: Burning, tingling, itching 12–24h before lesions
Lesions: Grouped vesicles on erythematous base → pustules → erosions → crusts
Distribution: Often dermatomal or localized cluster; may cross midline (unlike zoster)
Systemic: Fever, malaise, lymphadenopathy (more common in primary infection)
Duration: 7–14 days untreated; 4–7 days with antivirals

Differential Diagnosis

Condition	Distinguishing Features
Herpes zoster (shingles)	Strictly dermatomal, unilateral, severe neuralgic pain, older/immunocompromised
Contact dermatitis	Pruritic, eczematous, geometric borders, no vesicles typically
Folliculitis	Pustules centered on hair follicles, no grouping
Impetigo	Honey-colored crusts, S. aureus/S. pyogenes, contagious
Candidiasis	Satellite pustules, intertriginous, KOH positive

Diagnostic Confirmation

PCR swab (gold standard): High sensitivity, typing (HSV-1 vs HSV-2)
Viral culture: Lower sensitivity, slower
Tzanck smear: Multinucleated giant cells; not type-specific, low sensitivity
Serology (type-specific IgG): Past infection; not for acute diagnosis

Treatment

Scenario	Regimen
First episode	Acyclovir 400mg TID × 7–10d, or Valacyclovir 1g BID × 7–10d
Recurrent episodic	Valacyclovir 1g BID × 1d or 500mg BID × 3d (start at prodrome)
Suppressive	Valacyclovir 500mg–1g daily (reduce frequency 70–80%, shedding 90%)
Severe/immunocompromised	IV acyclovir 5–10mg/kg q8h

Patient Counseling

Initiate therapy at earliest prodrome for best effect
Avoid touching lesions; wash hands after contact
Abstain from skin-to-skin contact while lesions present
Disclose status to partners; condoms reduce but don't eliminate transmission
Suppressive therapy reduces transmission by ~50%

Abdominal herpes is uncommon but clinically indistinguishable from other cutaneous HSV. Prompt antiviral therapy shortens course and reduces complications.